A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older.

MLA

Steens, A., et al. “A Review of the Evidence to Inform Pneumococcal Vaccine Recommendations for Risk Groups Aged 2 Years and Older.” Epidemiology and Infection, vol. 142, no. 12, Dec. 2014, pp. 2471–82. EBSCOhost, https://doi.org/10.1017/S0950268814001514.

APA

Steens, A., Vestrheim, D. F., Aaberge, I. S., Wiklund, B. S., Storsaeter, J., Riise Bergsaker, M. A., Rønning, K., & Furuseth, E. (2014). A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older. Epidemiology and Infection, 142(12), 2471–2482. https://doi.org/10.1017/S0950268814001514

Chicago

Steens, A, D F Vestrheim, I S Aaberge, B S Wiklund, J Storsaeter, M A Riise Bergsaker, K Rønning, and E Furuseth. 2014. “A Review of the Evidence to Inform Pneumococcal Vaccine Recommendations for Risk Groups Aged 2 Years and Older.” Epidemiology and Infection 142 (12): 2471–82. doi:10.1017/S0950268814001514.